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ABSTRACT
Background: In recent years, eye movement desensitization and reprocessing (EMDR) has 
been applied to different psychiatric conditions beyond post-traumatic stress disorder 
(PTSD), and an increasing number of studies have evaluated its effect on depression. To 
date, no quantitative synthesis of the efficacy of EMDR on depression has been conducted.
Objective: To meta-analytically review the studies on EMDR for depression as the primary 
target for treatment.
Method: Studies with a controlled design evaluating the effect of EMDR on depression were 
searched on six electronic databases (PubMed, Embase, CINAHL, PsycINFO, Cochrane data-
base, and Francine Shapiro Library) and then selected by two independent reviewers. 
A systematic review and meta-analysis was conducted.
Results: Eleven studies were included for qualitative synthesis. Nine studies were included 
in the meta-analysis, involving 373 participants. The overall effect size of EMDR for depres-
sive symptoms is large (n = 9, Hedges’ g = – 1.07; 95%CI [–1.66; – 0.48]), with high 
heterogeneity (I2 = 84%), and corresponds to a ‘number needed to treat’ of 1.8. At follow- 
up (range 3–6 months), the effect remains significant but moderate (n = 3, Hedges’ 
g = – 0.62; 95%CI [–0.97; – 0.28]; I2 = 0%). The effect of EMDR compared with active controls 
is also moderate (n = 7, g = – 0.68; 95%CI [–0.92; – 0.43]; I2 = 0%). No publication bias was 
found, although the results are limited by the small number and poor methodological 
quality of the included studies.
Conclusions: Review findings suggest that EMDR may be considered an effective treatment 
for improving symptoms of depression, with effects comparable to other active treatments. 
However, findings need to be interpreted in light of the limited number of the studies and 
their quality. Further research is required to understand the longer-term of effects EMDR in 
treating depression and preventing depression relapse.
Protocol registration: PROSPERO (CRD42018090086).
Desensibilización y reprocesamiento por movimientos oculares para la 
depresión: una revisión sistemñtica y meta-análisis
Antecedentes: En los últimos años, la desensibilización y reprocesamiento por movimientos 
oculares (EMDR) se ha aplicado a diferentes condiciones psiquiátricas más allá del trastorno 
de estrés postraumático (TEPT), y un número creciente de estudios ha evaluado su efecto en 
la depresión. Hasta la fecha, no se ha realizado ninguna síntesis cuantitativa de la eficacia de 
la EMDR en la depresión.
Objetivo: Revisar meta-analíticamente los estudios de EMDR para la depresión como 
objetivo principal del tratamiento.
Método: Se buscaron estudios con un diseño controlado que evaluaran el efecto de la 
EMDR en la depresión en seis bases de datos electrónicas (PubMed, Embase, CINAHL, 
PsycINFO, base de datos Cochrane y Francine Shapiro Library) y luego fueron seleccionados 
por dos revisores independientes. Se realizó una revisión sistemática y un metanálisis.
Resultados: Se incluyeron once estudios para la síntesis cualitativa. Se incluyeron nueve 
estudios en el meta-análisis, con 373 participantes. El tamaño del efecto global de la EMDR 
para los síntomas depresivos es grande (n = 9, g de Hedges = −1,07; IC del 95% [−1,66; 
−0,48]), con alta heterogeneidad (I2 = 84%), y corresponde a un ‘número necesario a tratar’ 
de 1,8. En el seguimiento (rango 3-6 meses), el efecto sigue siendo significativo pero 
moderado (n = 3, g de Hedges = −0,62; IC del 95% [−0,97;-0,28]; I2 = 0%). El efecto del 
EMDR en comparación con los controles activos también es moderado (n = 7, g = −0,68; IC 
del 95% [−0,92;-0,43]; I2 = 0%). No se encontró ningún sesgo de publicación, aunque los 
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• This review summarizes 
the current evidence on the 
effects of EMDR for 
depression. 
• Findings show that one- 
third of people with 
depression could benefit 
from EMDR. 
• EMDR could be considered 
as an alternative to first-line 
treatments for depression, 
pending further research. 
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resultados están limitados por el pequeño número y la pobre calidad metodológica de los 
estudios incluidos.
Conclusiones: Los resultados de la revisión sugieren que la EMDR puede considerarse un 
tratamiento eficaz para mejorar los síntomas de la depresión, con efectos comparables a los 
de otros tratamientos activos. Sin embargo, los hallazgos deben interpretarse a la luz del 
número limitado de los estudios y su calidad. Se requiere investigación adicional para 
comprender los efectos a largo plazo de la EMDR en el tratamiento de la depresión y la 
prevención de la recaída de la depresión.
Registro del protocolo: PROSPERO (CRD42018090086).
抑郁的眼动脱敏和再加工:系统综述和元分析




方法:在六个电子数据库 (PubMed, Embase, CINAHL, PsycINFO, Cochrane数据库和Francine 
Shapiro库) 中搜索包含评估EMDR对抑郁症影响的对照设计的研究, 然后由两名独立的审阅 
者进行选择。进行了系统综述和元分析。
结果:纳入了11项定性综合研究。元分析包括九项研究, 共373名参与者。 EMDR对抑郁症 
状的总体效应量较大 (n = 9, Hedges’ g= −1.07; 95％CI [−1.66; −0.48]), 异质性较高 (I2 = 
84％), 对应于1.8的’需要治疗的数量’。在随访时 (3-6个月), 效果仍然显著但中等 (n = 3, 
Hedges’ g= −0.62; 95％CI [−0.97; −0.28]; I2 = 0％) 。与主动对照组相比, EMDR的作用也中 
等 (n = 7, g= −0.68; 95％CI [−0.92; −0.43];I2 = 0％) 。没有发现发表偏倚, 尽管结果受限于纳 
入研究的数量较少和方法质量较差。





Depression is widespread in the world with a prevalence 
that ranges between 2.6% (among males in the Western 
Pacific Region) and 5.9% (among females in the African 
Regions), with a peak in late adulthood and a higher rate 
for women than for men (World Health Organization, 
2017). This disease impacts on people’s quality of life and 
functioning. In this regard, in 2017 the World Health 
Organization identified depression as one of the major 
causes of reduced life years due to mortality and disabil-
ity (James et al., 2018). According to the Diagnostic and 
Statistical Manual of Mental Disorders, 5th Edition 
(DSM-5), depression assumes clinical relevance when it 
leads to significant distress or impairment in social, 
occupational, or other important areas of functioning 
and meets the diagnostic criteria for an episode of 
major depressive disorder (American Psychiatric 
Association, 2013).
The treatment of depression has greatly evolved over 
the last few years and there are now various therapeutic 
options that combine pharmacology and psychotherapy 
(National Institute for Health and Care Excellence, 2009, 
2018). However, less than half of the treated patients 
(Johnston, Powell, Anderson, Szabo, & Cline, 2019) 
show a positive response to drug therapy (i.e. 
a reduction in depressive symptoms) and, although the 
introduction of cognitive behavioural therapy (CBT) has 
allowed a doubling of the percentage of responders 
(Hofmann et al., 2014), recurrence rates at 1 and 
2 years remain high at 29% and 54%, respectively 
(Vittengl, Clark, Dunn, & Jarrett, 2007).
Among the main risk factors for depression, trau-
matic events play a crucial role. This seems particularly 
evident when considering that psychiatric patients show 
an 89.9% prevalence of early traumatic experiences 
compared to 50% for the general population 
(Schalinski et al., 2016). The causal relationship between 
traumatic events and the onset of a depressive disorder 
is complex and has yet to be fully outlined. However, it 
is likely that the impact of traumatic experiences is 
mediated by an individual’s epigenetic, immunological, 
endocrine (Caldji et al., 1998; Huot, Plotsky, Lenox, & 
McNamara, 2002; Ladd et al., 2000; Liu, 1997; Meaney 
et al., 1996; Plotsky & Meaney, 1993), neurobiological 
(Andersen et al., 2008; Davey, Yücel, & Allen, 2008; 
Ernst, Pine, & Hardin, 2006) and psychological mod-
ifications (Aldao, Nolen-Hoeksema, & Schweizer, 
2010a; Courtney, Kushwaha, & Johnson, 2008; Crow, 
Cross, Powers, & Bradley, 2014; Maciejewski & Mazure, 
2006; Wright, Crawford, & Del Castillo, 2009). 
Exposure to adverse events during childhood and ado-
lescence is not only a significant risk factor for devel-
oping a depressive disorder but also influences the 
course, prognosis, and response to treatments. Indeed, 
this exposure has been shown to be one of the main 
factors in recurrence, persistence, and resistance to the 
treatment of depression (Nanni, Uher, & Danese, 2012; 
Nelson, Klumparendt, Doebler, & Ehring, 2017). 
Furthermore, it seems to increase the individual sensi-
tivity of the disorder to psychotherapeutic interven-
tions, which in these cases are more effective than 
drug therapy (Nemeroff et al., 2003). Relying on these 
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findings, some authors proposed considering trauma- 
associated depression as a particular subtype, which 
would require a different approach compared to the 
traditional one proposed by the guidelines (Minelli 
et al., 2019; Nanni et al., 2012; Nelson et al., 2017; 
Paterniti, Sterner, Caldwell, & Bisserbe, 2017).
Eye movement desensitization and reprocessing 
(EMDR) is a first-choice therapy in post-traumatic 
stress disorder (PTSD) and is based on the adaptive 
information processing (AIP) model proposed by 
Shapiro (Shapiro, 2018). Such a model proposes the 
influence of dysfunctional memories that have not 
been completely processed underlying various psychia-
tric disorders (such as PTSD, mood disorders, chronic 
pain, and drug addiction). These memories could be 
triggered by internal or external stimuli, thus assuming 
an intrusive nature and accompanying appearance of 
PTSD symptoms and other disorders (Hase et al., 2018). 
According to Barry and collaborators (Barry, Naus & 
Rehm, 2006), dysfunctional memories are characterized 
by a lack of ‘memory awareness’ as a consequence of 
their incomplete processing. EMDR therapy targets this 
lack of awareness by reprocessing such pathogenic 
memories with the use of alternate bilateral stimulations 
(e.g. eye movements), thus enabling their transforma-
tion and integration into already existing semantic links 
(Hase, Balmaceda, Ostacoli, Liebermann, & Hofmann, 
2017; Solomon & Shapiro, 2008).
Recently, a specific EMDR therapy protocol for the 
treatment of depressive disorders (DeprEND®) has been 
published (Hofmann et al., 2016). Research findings 
have shown that EMDR could contribute to 
a significant reduction of depressive symptoms asso-
ciated with PTSD when compared to waitlist/usual care 
or non-trauma-focused CBT. However, these findings 
are supported by very low-quality evidence (Bisson, 
Roberts, Andrew, Cooper, & Lewis, 2013; Cuijpers, 
van Veen, Sijbrandij, Yoder, & Cristea, 2020).
Moreover, in recent years EMDR has been applied 
to the treatment of psychiatric disorders beyond 
PTSD, such as depression, although it is not currently 
recommended by the guidelines (Cuijpers et al., 2020; 
Valiente-Gómez et al., 2017). Therefore, it is essential 
to determine whether EMDR is an evidence-based 
treatment for depression.
Previous reviews addressing this topic have been 
published (Carletto et al., 2017; Malandrone, Carletto, 
Hase, Hofmann, & Ostacoli, 2019; Wood & Ricketts, 
2013), suggesting the potentiality of EMDR for 
depression but also highlighting the paucity of meth-
odologically sound studies conducted until then. As 
other studies have been conducted in recent years, 
including some randomized controlled trials (RCTs), 
the present systematic review and meta-analysis aims 
to update and add a quantitative analysis on the 
efficacy of EMDR for the treatment of depression.
2. Methods
2.1. Protocol registration
The review protocol was registered in the PROSPERO 
repository (CRD42018090086). The original protocol 
recorded on PROSPERO has undergone some varia-
tions. In particular, the search has been updated and 
the meta-analysis focused on depression considered as 
a primary diagnosis and outcome.
The systematic review and meta-analysis was carried 
out following the PRISMA statement and the PRISMA 
checklist (Moher, Liberati, Tetzlaff, & Altman, 2010) 
and it was drafted following the Cochrane Handbook 
Guidelines (Higgins et al., 2019).
2.2. Search strategy for identification of studies
Searches were conducted in the following databases 
on 30 September 2020: PubMed, Embase, CINAHL, 
PsycINFO and the Cochrane Central Register of 
Controlled Trials. Moreover, we performed a search 
with the keyword ‘depress’ in the Francine Shapiro 
Library, which is an online compendium of confer-
ence presentations, scholarly articles, and other 
important grey literature related to EMDR. From 
selected studies, cross-references were checked manu-




We included studies with a controlled trial design, 
either randomized or not. No year or language 
restrictions were applied.
2.3.2. Population
Trials included patients of any age with depression as 
a primary diagnosis and primary outcome of the 
study. Depression is defined as either major depres-
sive disorder or depressive symptoms (above or 
below a predefined cut-off on the questionnaires 
employed in each study). There was no restriction 
by concurrent organic disease.
2.3.3. Intervention and comparison
We included studies that evaluated EMDR intervention 
alone or in addition to another treatment in compar-
ison with no intervention, waiting list, treatment as 
usual, or other types of intervention (e.g. antidepres-
sant medication, CBT, psychodynamic therapy).
2.3.4. Outcome
We included studies with depression as a primary out-
come. Studies were supposed to include quantitative 
data on depressive scores, as measured by standardized 
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psychometric scales, before and after the intervention/s. 
Finally, in order to be included in the meta-analysis, 
studies also had to provide enough data to calculate 
effect sizes.
2.4. Data collection and analysis
2.4.1. Study selection and appraisal
Two authors (S.C. and F.M.) independently con-
ducted standardized assessments to determine study 
eligibility according to the inclusion criteria. They 
screened the abstracts and then retrieved and ana-
lysed the full texts for all material deemed relevant. 
Any disagreement was discussed with a third author 
(L.O.) before agreement was reached.
2.4.2. Data extraction
Data from the selected studies were inserted into 
a standard template by two independent researchers (S. 
C. and F.M.). Extracted data covered publication year, 
publication type, language, study design, population, 
primary diagnosis, sample size (for both experimental 
and control groups), duration and type of intervention, 
duration and type of comparator, depression measure 
and length of follow-up. Article authors were contacted 
via email for missing information.
2.4.3. Risk of bias in individual studies
The internal validity of the RCTs was assessed using 
Version 2 of the Cochrane risk-of-bias tool for ran-
domized trials (RoB 2) (Sterne et al., 2019), which 
consists of five domains (randomization process, 
deviations from intended interventions, missing out-
come data, measurement of the outcome, selection of 
the reported result) and a categorization of the overall 
risk of bias. Risk of bias of controlled studies was 
assessed using the MINORS scale (Slim et al., 2003; 
Zeng et al., 2015). For all included studies, quality 
was also assessed using the platinum standard (PS) 
(Hertlein & Ricci, 2004), which was specifically 
designed to evaluate effectiveness in EMDR research. 
Assessment of the risk of bias was made by two 
independent coders (S.C. and F.M.) and any disagree-
ments were discussed and resolved with a third 
reviewer (L.O.).
2.4.4. Summary measures
For each study, the mean change from baseline (post- 
score – baseline score) was computed. Because the 
included studies used different scales for measuring 
depression, effect sizes were computed as the stan-
dardized mean difference based on Hedges’ g method 
(Hedges & Olkin, 1985). Moreover, as the correlation 
coefficient between the post- and baseline scores is 
needed for computing the standard error, the value of 
0.7 was assigned, as suggested by Rosenthal (1991).
The DerSimonian and Laird random-effects 
model was used to pool estimates across studies 
(DerSimonian & Laird, 1986). Average effect size 
and 95% confidence interval (95%CI) were com-
puted using the Jackson method. The number 
needed to treat (NNT) was calculated with the for-
mulae provided by Kraemer and Kupfer (2006). To 
estimate heterogeneity between studies, Cochran’s 
Q test and the Higgins I2 statistic were used. 
Similarly, subgroup analyses were carried out using 
random-effects models by considering the risk of 
bias. The extent to which different treatment doses 
affect the effect size was examined by applying 
a univariate meta-regression. To identify influential 
studies that resulted in variation, a sensitivity ana-
lysis was carried out using GOSH (graphical display 
of study heterogeneity) plots, which fit the same 
meta-analysis model for all the possible study com-
binations and look for specific patterns by perform-
ing clustering with k-means, DBSCAN (density- 
based spatial clustering of applications with noise) 
and Gaussian mixed models (Olkin, Dahabreh, & 
Trikalinos, 2012). Publication bias was examined 
by visual inspection of funnel plots and using 
Egger’s test (Egger, Smith, Schneider, & Minder, 
1997). Analyses were carried out using R version 
3.6.1 (R Development Core Team, 2019).
3. Results
3.1. Study selection and study characteristics
The PRISMA flowchart describing the selection pro-
cess, including reasons for exclusion, is presented in 
Figure 1. The search retrieved 11 studies: 10 articles 
on adult patients and one on adolescents (Table 1). 
Meta-analysis included 9 studies, as two studies (Lei 
& Zhen-Ying, 2007; Tang et al., 2015) was excluded 
due to there being no usable data for calculating the 
effect sizes.
The meta-analysis involved 373 participants, with 
177 allocated to EMDR treatment and 196 controls.
Ten studies were published in journals and one was 
a PhD dissertation thesis. All except one were in 
English. The first published study dates back to 2007 
and the last in 2020. Regarding the study design, eight 
studies were RCTs and three were controlled studies 
(CS). None of the studies included patients with a PTSD 
diagnosis. The presence of traumatic experiences was 
considered as an inclusion criterion in only one of the 
studies (Minelli et al., 2019), whereas in the other stu-
dies it was assessed among other variables. Concerning 
the use of medication, one study considered it to be an 
exclusion criterion, one study reported no information, 
and nine studies chose to keep stable or not exclude the 
use of antidepressants. In five studies, the efficacy of 
EMDR was investigated as an add-on to other 
4 S. CARLETTO ET AL.
psychotherapies, medications, or psychoeducation, and 
six studies compared EMDR as a stand-alone treatment. 
When EMDR was investigated as a stand-alone treat-
ment, two studies compared EMDR with a waiting list/ 
no treatment control group, whereas four studies com-
pared EMDR with an active control. Among the latter, 
all studies compared EMDR with CBT. The average 
amount of EMDR therapy administered is 16.97 hours 
(SD = 16.53) and the average amount of control treat-
ment is 19.08 hours (SD = 15.94). Although six studies 
planned a follow-up evaluation, only four studies pro-
vided data for including in the meta-analysis.
3.2. Risk of bias within studies
The risk of bias for each study is reported in Table 2 
and Figure S2. Eight RCTs were assessed with RoB 2. 
The quality of the included studies was not optimal: 
the overall risk of bias was rated as low in only 22.2% 
of the studies. The major issues identified were 
related to deviation from the intended intervention, 
in particular the lack of intention-to-treat analysis 
and inadequate reporting of allocation concealment.
The three controlled studies showed a high risk of 
bias, mainly related to missing methodological infor-
mation. Quality assessment according to the PS is 
reported in Supplementary Material S3. The total PS 
score for each study ranged from 6.5 to 11.5 (max-
imum of 13), with a mean of 8.73 (SD = 1.63). Almost 
all studies were judged to have clearly defined target 
symptoms, reliable and valid measures and used 
a control or comparison group. Moreover, almost 
all studies reported the level of therapist(s) training 
and applied a manualized, replicable, specific EMDR 
treatment. The lowest PS scores are mainly related to 
not reporting information regarding the assessors’ 
training, effect size and level of treatment adherence. 
Finally, in only two studies was the treatment length 
11 or more sessions, which is considered the thresh-
old to achieve an effect according to the PS guidelines 
(Hertlein & Ricci, 2004). Overall, the PS scores were 
largely consistent with the judgement of risk of bias 
provided by RoB 2/MINORS.
3.3. Synthesis of results
The forest plot of the overall effect of EMDR is 
reported in Figure 2. EMDR results in a large sig-
nificant effect on depressive symptoms (n = 9, 
Hedges’ g = – 1.07; 95%CI [–1.66, – 0.48]), with 
high heterogeneity (I2 = 84%). The effect size corre-
sponds to an NNT of 1.8. Exclusion of one outlier 
Records identified through 
database searching 























Additional records identified 
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Full-text articles assessed 
for eligibility 
(n = 15)
Full-text articles excluded 
(n = 4, lack of depression 
or depressive symptoms 
as inclusion criterion) 
Studies included in 
qualitative synthesis 
(n = 11)
Studies included in 
quantitative synthesis 
(meta-analysis) 
(n = 9) 
Figure 1. PRISMA flow diagram.
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resulted in a smaller but still moderately significant 
effect size for post-treatment (n = 8, g = – 0.75; 95% 
CI [–0.99, – 0.50], NNT = 2.5; forest plot S5), with 
low heterogeneity (I2 = 2%). At follow-up, the effect 
is still significant (n = 3, g = – 0.62; 95%CI [–0.97, 
– 0.28]; forest plot S6) with no heterogeneity 
(I2 = 0%). As can be seen in Figure 3, low-quality 
studies showed a higher effect size than those of 
high quality. Considering only the latter, EMDR 
showed a moderate effect (n = 2, g = – 0.75; 95% 
CI [–1.13, – 0.37]) with no heterogeneity (I2 = 0%; 
Figure 3). The effect of EMDR was compared with 
an active control group in seven studies, showing 
a moderate effect (n = 7; g = – 0.68; 95%CI [–0.92, 
– 0.43]; forest plot S7) with no heterogeneity 
(I2 = 0%). In three studies, EMDR was compared 
to CBT, resulting in a still significant moderate 
effect size (n = 3, g = – 0.68; 95%CI [–1.03, 
– 0.33]; forest plot S8) with no heterogeneity 
(I2 = 0%). In four studies, EMDR was an add-on to 
Figure 2. Overall effect of EMDR for depression: forest plot.
Figure 3. Overall effect with risk of bias: forest plot.
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another treatment, showing a moderate effect 
(g = – 0.68; 95%CI [–1.02, – 0.33] with no hetero-
geneity (I2 = 0%). The forest plot is reported in 
Supplementary Material S9. A dose–response effect 
on EMDR effect size at post-treatment was not 
observed (n = 7, β = 0.0003; p = 0.4231).
3.4. Risk of bias across studies
Neither visual inspection of funnel plots nor Egger’s 
test showed any evidence of publication bias (Figure 4 
Figure 5).
4. Discussion
The aim of this systematic review and meta-analysis 
was to update the state of the art and add 
a quantitative analysis on EMDR therapy for depres-
sion as the primary target for treatment.
To our knowledge, this is the first meta-analysis on 
this topic. Although EMDR is typically associated with 
the treatment of PTSD, the AIP model (Shapiro, 2001) 
opens up the possibility to treat other mental health 
conditions with a trauma-focused approach (Hase et al., 
2017).
The results from the nine studies included in the 
present meta-analysis show that EMDR has a large 
effect, although high heterogeneity was found and 
only two studies present a low risk of bias. The statistical 
effect also reflects clinical significance, as one-third of 
people with depression benefit from EMDR therapy. In 
the limited number of studies where follow-up data was 
available positive effect of EMDR treatment were main-
tained but with a smaller effect. It should be noted that 
this latter finding is based on only three studies, so 
future studies are needed. The effect was moderate 
even when EMDR is compared with active controls 
and when compared directly with CBT. These results 
are strengthened by the absence of heterogeneity, there-
fore EMDR could be considered as an effective trauma- 
focused treatment for depression. The effectiveness of 
EMDR appeared not to be related to the treatment dose 
received. This is in line with previous studies, which 
showed no psychotherapy dose–response relationship 
for depression (Barth et al., 2013; Stulz, Lutz, Kopta, 
Minami, & Saunders, 2013). Furthermore, it is impor-
tant to consider the limited range of EMDR sessions in 
the studies conducted so far. The effect sizes obtained in 
this meta-analysis are similar or superior to other meta- 
analyses evaluating the effects of CBT and other psy-
chotherapies for depression (Cuijpers, Huibers, Daniel 
Ebert, Koole, & Andersson, 2013; Cuijpers, Van Straten, 
Andersson, & Van Oppen, 2008) that are currently 
recommended as effective treatments for depression in 
the clinical guidelines (National Institute for Health and 
Care Excellence, 2018; Parikh et al., 2009). This finding 
is in line with evidence showing that different types of 
psychotherapies have comparable effects (Barth et al., 
2013; Cuijpers, Quero, Dowrick, & Arroll, 2019; 
Cuijpers et al., 2008). However, our meta-analysis 
included only 9 studies, compared to more than 100 
studies in other meta-analyses, thus highlighting the 
need for high-quality studies to further evaluate the 
effect of EMDR for depression.
4.1. Strengths and limitations of the studies
In general, the studies have several limitations. As 
expected from studies in a field that is still in its 
infancy, several methodological limitations were 
found, such as small sample size, high risk of bias, 
and high heterogeneity. Less than half of the studies 
evaluated the long-term effect of EMDR on depres-
sion. Treatment fidelity was independently checked 
and considered as adequate in only three studies.
The studies also have some strengths. In most 
articles, the outcome evaluation criteria were well 
explained and the assessment tools were all validated. 
Furthermore, in recent years an increasing number of 
RCTs addressing the effectiveness of EMDR in treat-
ing depression as a primary outcome have been pub-
lished, along with an increase in their methodological 
quality. A manualized treatment protocol was applied 
in the great majority of studies and data on the 
competence of the therapists were provided in all 
but one of the studies.
4.2. Strengths and limitations of this review
To our knowledge, this is the first meta-analysis on 
the effectiveness of EMDR in the treatment of depres-
sion as a primary outcome, going beyond previous 
research that evaluated its effect as an associated 
symptom in patients with PTSD (Bisson et al., 2013; 
Cuijpers et al., 2020). Moreover, the Francine Shapiro Figure 4. Funnel plot.
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Library was consulted to retrieve grey literature, thus 
conducting a comprehensive review as suggested in 
the Cochrane handbook (Higgins et al., 2019). This 
meta-analysis does have some limitations. First of all, 
the number of included studies is small, indicating 
that the interest in research on the application of 
EMDR for depression is still in its infancy. 
Secondly, the majority of the studies were character-
ized by low methodological quality and only a few 
studies examined long-term effects, thus limiting 
interpretation of the results of this meta-analysis. 
Finally, another limitation was represented by the 
impossibility of retrieving data for two studies, 
which therefore were not included in our quantitative 
synthesis.
4.3. Implications for clinical practice and 
research
The results of this study can inform clinical practice 
by considering EMDR effective at reducing depres-
sion, thus adding an additional therapeutic option for 
clinicians treating this disorder. The increase of ther-
apeutic strategies for depression is of particular 
importance as it allows better personalization to be 
provided according to patients’ preferences. In fact, 
studies have shown that receiving a preferred treat-
ment is associated with stronger therapeutic alliance, 
lower dropout rates, and positive treatment outcomes 
(Lindhiem, Bennett, Trentacosta, & McLear, 2014; 
Swift, Callahan, Cooper, & Parkin, 2018; Windle 
et al., 2020). It is also essential to routinely evaluate 
the presence of adverse childhood experiences and 
traumatic events in people with depression in order 
to identify if trauma-focused psychotherapies such as 
EMDR could be more effective for patients with 
a history of maltreatment. Previous studies have 
shown that exposure to childhood maltreatment pre-
dicts a poorer response to drug treatment (Nanni 
et al., 2012; Williams, Debattista, Duchemin, 
Schatzberg, & Nemeroff, 2016) and a better response 
to psychotherapy (Nemeroff et al., 2003) in patients 
with depression. Therefore, trauma-focused therapies 
could represent a valid option for patients with 
depression, who are less likely to respond to usual 
treatments and may require specific interventions 
focused on their maltreatment history. It may also 
be useful to consider whether different types of 
adverse childhood experiences play a role in predict-
ing the outcome of treatment, in line with findings 
supporting a significant association of childhood mal-
treatment, especially emotional abuse and neglect, 
with depression (Humphreys et al., 2020; Mandelli, 
Petrelli, & Serretti, 2015; Nelson et al., 2017).
Among EMDR clinicians, evaluation of the type 
and sequence of treatment targets (e.g. current epi-
sode trigger; event(s) that gave rise to the series of 
recurring depressive episodes; belief system related to 
attachment history events) could be useful for 
improving therapeutic outcomes. More studies 
should also consider adopting the DeprEnd® protocol 
(Hofmann et al., 2016) as an EMDR intervention 
specific for depression, or at least report a more spe-
cific description of the intervention offered to 
patients, in line with current checklists such as the 
template for intervention description and replication 
(Hofmann et al., 2014). As effect sizes could be 
inflated by the inclusion of low-quality studies, 
further studies with better methodological quality 
are needed to obtain more reliable effect estimates. 
Future studies should include longer-term follow-up 
(i.e. after 1 and 2 years). This would make it possible 
to investigate whether EMDR could be effective not 
only for reducing depressive symptoms but also pre-
venting relapses, particularly in comparison with 
other interventions already recommended by clinical 
guidelines. Although treatment duration was not 
identified as a potential moderator of intervention 
efficacy either in this study or in previous reviews 
on CBT (Barth et al., 2013; Santoft et al., 2019), 
further studies should try to identify the ideal number 
of sessions to achieve a successful outcome. As emo-
tional dysregulation is a common clinical feature in 
patients with depression (Aldao et al., 2010a; Sloan 
et al., 2017), and previous research has found that this 
association is mediated by the exposition to traumatic 
events (Christ et al., 2019), it would be interesting for 
future research to explore the impact of EMDR on 
emotional regulation. Furthermore, no study has 
been conducted so far to evaluate the neurobiological 
effects of EMDR in depression.
To date, there is preliminary evidence on the effects 
of EMDR therapy on adolescents with depression 
(Bae, Kim, & Park, 2008; Paauw, De Roos, Tummers, 
De Jongh, & Dingemans, 2019). Previous reviews have 
shown encouraging, although limited, results on the 
effectiveness of EMDR in reducing depressive symp-
toms secondary to PTSD in children and adolescents 
(Manzoni et al., 2021; Moreno-Alcázar et al., 2017). 
Future controlled studies are needed to further evalu-
ate the effects of EMDR for depression as a primary 
target of the treatment among children and adoles-
cents. Future studies should analyse possible adverse 
effects and rates of attrition from EMDR treatment, as 
these aspects are essential to inform clinical practice. 
Finally, it would be interesting to investigate the 
impact on the economic and social costs of treating 
depression with EMDR compared to other psy-
chotherapies or pharmacotherapy.
5. Conclusion
The findings from this review suggest EMDR can be 
considered as an effective trauma-focused treatment 
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for reducing symptoms of depression, although sev-
eral methodological weaknesses were found in the 
included studies. Further studies are required in 
order to replicate these findings, improve methodo-
logical quality, and evaluate longer-term effects.
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